In 2017, CHIL was awarded a significant public tender in Pakistan for its HIV, HCV, and HBsAg Rapid Tests.
Competing against leading global manufacturers in the sector, CHIL secured the contract after successfully passing the official product performance evaluation tests, supported by its CE-certified regulatory credentials. The outcome reflected the technical reliability of the assays and their compliance with international quality standards.
This achievement marked an important milestone in CHIL’s expanding presence within regulated public health procurement programs.